Healthcare DIVE April 4, 2024
Emily Olsen

Advocacy groups, providers and virtual care companies said clinicians and pharmacies need time to comment on the rule and prepare for implementation.

Dive Brief:

  • Telehealth groups are urging the Drug Enforcement Administration to speed up a proposed rule that would allow and regulate the prescription of controlled substances through virtual care.
  • In a letter sent Tuesday to DEA Administrator Anne Milgram, more than 200 telehealth advocacy groups, providers and virtual care companies asked the agency to quickly release the regulation, as clinicians and pharmacies would need time to comment and prepare for implementation.
  • In October, the DEA and the HHS temporarily extended pandemic-era prescribing flexibilities for controlled substances through this year. The agency said it would work to create...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, Patient / Consumer, Provider, Technology, Telehealth
Related Articles:
Amwell’s Roy Schoenberg talks about telehealth and broader views of virtual care
The telehealth background of Trump's FDA pick: 6 notes
Teladoc expands virtual sitter capabilities
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?

Share This Article